Results 271 to 280 of about 96,828 (293)

Proteogenomic characterization identifies clinically relevant subgroups of intrahepatic cholangiocarcinoma

Cancer Cell, 2022
Liangqing Dong, Youpei Lin, Hongwen Zhu
exaly  

Promotion of cholangiocarcinoma growth by diverse cancer-associated fibroblast subpopulations

Cancer Cell, 2021
Silvia Affo, Ajay Nair, Francesco G Brundu   +2 more
exaly  

Pathogenesis of Cholangiocarcinoma

Annual Review of Pathology: Mechanisms of Disease, 2021
Paula Olaizola, Aloña Agirre-Lizaso, Luis Bujanda   +2 more
exaly  

Immunology and immunotherapy of cholangiocarcinoma

Nature Reviews Gastroenterology and Hepatology, 2023
Tim F Greten, Robert F Schwabe, Nabeel Bardeesy   +2 more
exaly  

Cholangiocarcinoma

Disease-a-Month, 2004
openaire   +2 more sources

Cholangiocarcinoma — novel biological insights and therapeutic strategies

Nature Reviews Clinical Oncology, 2023
Gonzalo Sapisochin, Ju Dong Yang, Gregory J Gores   +2 more
exaly  

Occupational cholangiocarcinoma

Journal of Hepato-Biliary-Pancreatic Sciences, 2014
Sai Tin, Sim, Viroj, Wiwanitkit
openaire   +2 more sources

Intrahepatic Cholangiocarcinoma

Annals of Surgery, 2009
Nuzzo G, Giuliante F, Ardito F, Giovannini I   +3 more
openaire   +3 more sources

[Cholangiocarcinomas].

Chirurgie (Heidelberg, Germany)
The term cholangiocarcinoma (CCA) includes a group of malignant tumors that develop in the efferent bile ducts and are characterized by a high degree of heterogeneity. These differences between intrahepatic, perihilar and distal CCAs run through all aspects of the disease including the etiology, pathogenesis, symptoms, diagnostics and treatment.
Wenzel, Schöning, Philipp K, Haber, Johann, Pratschke   +2 more
openaire   +1 more source

Cholangiocarcinoma — evolving concepts and therapeutic strategies

Nature Reviews Clinical Oncology, 2017
Sumera Rizvi, Robin Kate Kelley, Gregory J Gores   +2 more
exaly